Search this website. You can use fund codes to locate specific funds

Europe v US: For direct lenders, where is the relative value?

Direct lending is a promising market in Europe, but does it offer better opportunities than its more-established US counterpart? Here we assess the differences between the two and present our view on what it takes to invest successfully in European loans.

Europe: New kid on the bloc

Europe’s emergence as a direct lending market is still relatively recent. The changing regulatory landscape in the post-financial crisis era transformed loan markets. New capital adequacy rules, amplified by the Capital Requirements IV directive under Basel III, have forced banks to reduce risk and therefore the size of their loan books.

Prior to 2008, banks provided more than 80% of larger corporate loans in Europe. Data from S&P LCD1 shows the European loan market grew aggressively from €15bn in 1998 to €165bn in 2007, a year before the global financial crisis.

In its wake, small- and medium-sized (SME) businesses had little access to capital. Their borrowing needs could not reach the scale required to cost-efficiently access the bond market. This created a gap in the market for alternative lending, and investment firms have filled the void left by European banks to provide SME financing.

Direct lending now accounts for 10% of Europe’s loan market2. This rapid growth is in no small part driven by a surge of interest in the asset class. Investors with long-term liabilities are attracted by an illiquidity premium of almost 60bps, as well as a desire for strong yields that are lowly correlated with listed markets, capital preservation and inflation protection.

The US: Size matters

Across the Atlantic, the US remains the world’s largest direct-lending market. US bank disintermediation began in the early 1980s, spurred by regulatory changes and policies that promoted a market-based financing model for businesses.

As a result, the US market is deeper and more liquid than the European market. As of 2015, bank loans accounted for just 24% of non-financial corporate funding in the US, compared to more than 74% in Europe.

But does this greater size and depth ensure consistently better investment opportunities?

Europe v US: Compare the pair  

It is our view that, to be successful in the European market, investors must recognise its distinct characteristics and adapt their strategies in order to mitigate specific risks and capitalise on opportunities.

Risk and return: US funds tend to provide higher returns than European funds. That’s because they tend to use fund leverage, which is unusual in Europe. Levered funds generally come at a cost. Managers have a tendency to charge higher management fees, due to the higher potential returns on offer. To date, the majority of European investors have not been keen on fund leverage.

However, at loan transaction levels, Europe excels on measures of risk-adjusted returns. It generated 80bps of spread per unit of leverage in the second quarter of 2017, compared with 70bps in the US3. Although it is worth noting that historically European and US loan yields have been very similar.

Origination: Direct lending in Europe is a bank relationship-driven market. Banks control the majority of loans, which can make it difficult for direct lenders to access high-quality loans. But through strong origination networks – particularly those featuring formal co-lending agreements with European banks – investors can consistently access high-quality loans on an exclusive basis. As such, Europe is a much more efficient bank-led market for loans compared to the US, which is controlled by institutions. The US market is more than five times the size of the European market in terms of primary issuance (see Figure 1). And although the US market gives investors more depth of choice, its bank-led European peer is still growing in size.

Figure 1. Institutional loan volumes in the US and Europe


Source: S&P Global Market Intelligence as at June 2017.

Lower volatility: There are no retail investors in Europe, which in essence reduces volatility and the risk of technically-driven surges. Meanwhile, the presence of retail investors in the US means investors are likely to react to market developments quickly.

Oil and gas exposure: European bank loans have limited exposure to oil and gas. But the US market, given its scale, has a substantial number of companies affected by the ongoing volatility of oil prices, which has resulted in higher default rates in recent years compared to Europe.

Equity contribution: European loans are typically backed by more equity than those in the US, providing greater downside protection for debt investors. Over the past decade, data from S&P suggests that European leveraged loans had a greater percentage of average contributed equity. In the first half of 2017, equity as a percentage of total sources stood at 46% in Europe, compared to 40% for the US4.  Furthermore, the EV of companies in the US are getting more expensive: the average purchase price, as a multiple of trailing EBITDA, reached 10.3x in the first half of 2017 compared to 9.6x in Europe5.

Leverage multiples: Average leverage multiples on loans, measured as total debt to EBITDA, have climbed in both Europe and the US in the first six months of the year at 4.9x and 5.3x, respectively. This remains well below the peak leverage levels of 6.0x in 2007 6.

Average loan life: In Europe, the average life of a loan is longer than the US, which typically refinances after two years. A loan with a longer life provides companies with more time to deleverage and ultimately improve their credit quality.

Upfront fees: For European leveraged loans, upfront fees make up a substantially greater portion of overall yield for managers, usually around 3%. This compares to about 50bps7 in the US.

Documentation: Loan documentations and reporting requirements are more standardised in the US. In Europe, documentation differs on a country-by-country basis. Rather than being a drawback, this allows for more bespoke documentation that benefits direct lenders with expertise in loan structuring. These tailored agreements provide opportunities to negotiate stronger covenants and thereby secure greater downside protection.

Legal framework: The US is governed by a single rule of law. Under Chapter 11 of the US bankruptcy code, creditors are entitled to protection for a certain period of time. A similar legal framework does not exist in Europe. Instead, there are inconsistencies in solvency regimes across the region, with very creditor-friendly jurisdictions in Northern Europe and less creditor-friendly jurisdictions in certain countries such as France and Italy, which can make loan restructuring more complex.

Recovery rates and restructuring timeframes: The average recovery rate for UK loans currently stands at 89%, and the average time taken to restructure a loan is one year. Across the more creditor-friendly countries in the region – including the UK, Ireland, Germany, Scandinavia and the Benelux nations – the recovery rate is 87.2% and the average restructuring period is 1.1 years. This compares favourably with the US, where the average recovery rate is 77% and time taken to restructure is 1.5 years8.

Advantage Europe?

The direct lending landscapes of Europe and the US offer investors different risk-reward parameters. Yes, the US is the more established territory, but the rapid growth of direct lending in Europe and diversity within the market offer many benefits, which include:

  • Attractive upfront fees
  • Lower volatility
  • High equity contributions
  • Lower average leverage multiples
  • Limited exposure to oil and gas markets
  • Longer average loan life
  • Higher recovery rates in Northern Europe

We believe that a Northern Europe-focused direct lending strategy driven by a skilled team with a strong origination capability can exploit opportunities that can match or surpass those found in the US.

In Europe, origination is key

We aim to provide investors with a healthy yield plus capital preservation. The Hermes Direct Lending Strategy targets returns of LIBOR plus 6% on a gross annualised basis by investing primarily in senior-secured loans, which ensure that investors receive income before all others and guarantee first claim on assets in the event of default, to a diverse range of high-quality SMEs. These businesses typically generate EBITDA of between €5m and €45m.

The Strategy has exclusive access to high-quality loans due to our origination contacts in Europe and a co-lending agreement with the Royal Bank of Scotland (RBS), the UK’s second-largest creditor to SMEs. Under this agreement, RBS is legally bound to invite us to participate in all new loans on equal economic terms, while we independently conduct credit analysis and due diligence, and retain discretion over any deal we commit to.

We aim to be credit ‘pickers’ rather than credit ‘takers’ – that is, to ensure that we have consistently strong deal flow in order to select the best loans to invest in on behalf of our investors.

Video: Why invest in European and not US loans?

Mark Miller, Head of UK & MENA Institutional, and Patrick Marshall, Head of Private Debt and CLOs, discuss the differences between the European and US markets and what it takes to invest successfully in European loans.


Hermes Podcast: Europe v US: For direct lenders, where is the relative value?

  1. 1"LCD Global Review – US/Europe”, published by S&P Global Market Intelligence on 04 2017
  2. 2“European direct lenders give banks a run for their money”, published by Reuters on 12 2016
  3. 3“LCD Global Review – US/Europe”, published by S&P Global Market Intelligence on 04 2017
  4. 4“LCD Global Review – US/Europe”, published by S&P Global Market Intelligence on 04 2017
  5. 5"LCD Global Review – US/Europe”, published by S&P Global Market Intelligence on 04 2017
  6. 6“LCD Global Review – US/Europe”, published by S&P Global Market Intelligence on 04 2017
  7. 7“Direct Lending: What’s Direct Now?”, published by bfinance on 03 2017
  8. 8“Resolving Insolvency”, published by The World Bank on 06 2016.

This document has been prepared using information which is confidential and proprietary to The Royal Bank of Scotland plc (“RBS”, “we”, “us” and “our”). This document and any dispute arising under or in connection therewith is to be governed by and construed in accordance with English law.

This document is being issued to you (the “Recipient” or “you” or “your”) by Hermes Investment Management Limited (“Hermes”) solely in connection with your potential investment in a direct lending fund being established by Hermes (the “Specified Purpose”).

RBS and Hermes (the “Institutions”) are separate institutions each acting on their own behalf and not as agent or for the benefit of any other person. Nothing in this material is intended to, or shall be deemed to: (i) establish or represent any partnership or joint venture between the Institutions; (ii) constitute any Institution as the agent of the other Institution; or (iii) constitute any Institution making or entering into any representation, commitment or assurance of any kind for or on behalf of any other Institution.

Any information in this document which relates to or refers to RBS and/or its Financial Sponsors business (“RBS Confidential Information”) is confidential and must not be disclosed in a manner inconsistent with the Specified Purpose. Where you have entered into a confidentiality agreement with Hermes in respect of this document and/or the RBS Confidential Information you must comply at all times with the terms of any such confidentiality agreement(s) and the use restrictions therein.

This document does not constitute an offer or invitation by RBS in respect of the Specified Purpose or any financing or any other sale or purchase of securities. The RBS Confidential Information is not intended for distribution to, or use by any person or entity in any jurisdiction or country where such distribution or use would be contrary to local law or regulation and must not be reproduced or disclosed (in whole or in part) to any other person without our prior written consent.

The RBS Confidential Information is not and does not purport to be comprehensive and we have no obligation to update it. Any information in this document provided by RBS has not been verified independently. The RBS Confidential Information is provided on a strictly non-reliance basis and should not be relied upon as the basis for an investment decision. In compiling the RBS Confidential Information we have relied upon and assumed, without verification, the accuracy and completeness of all information available to us. No representation or warranty, express or implied, is or will be made and no responsibility or liability is or will be accepted by RBS or any of its affiliates or by any of its respective officers, employees or agents in relation to the accuracy or completeness of any part of this document or any other written or oral information made available to you, your affiliates, connected companies, employees or advisers (and any such liability is expressly disclaimed). In particular, but without prejudice to the generality of the foregoing, no representation or warranty is given as to the achievement or reasonableness of any returns, projections, estimates, valuations or prospects contained in any part of this document or in such other written or oral information.

The Recipient acknowledges and agrees that no person has, nor is held out as having any authority to give any statement, warranty, representation, or undertaking on behalf of RBS in respect of the RBS Confidential Information. We give no undertaking to provide the Recipient with access to any additional information, to determine the accuracy or reasonableness of information or assumptions, to update this document or any additional information, or to correct any inaccuracies in it which may become apparent. Any views expressed in this document in respect of RBS Confidential Information (including statements or forecasts) constitute the judgment of RBS as of the date given and are subject to change at any time without notice.

You are solely responsible for compliance with law and regulations which may apply to this document and the Specified Purpose in jurisdictions applicable to you and your affiliates. This document does not constitute an offer to sell or an invitation to purchase securities in any jurisdiction. The RBS Confidential Information is not to be construed as legal, tax, regulatory, accounting, investment or business advice, and is not intended to form the basis of any investment decision. You should consult your own advisers on such matters as you deem appropriate.

This document is provided to you on the basis that you understand that RBS is not providing you with any "investment advice" within the meaning of Article 53 of the FSMA 2000 (Regulated Activities) Order 2001 and as a result, RBS is under no obligation to assess the suitability of the information provided in light of your knowledge and experience, financial situation and/or investment objectives. A consequence of the above is that RBS will not provide you with advice on the merits of buying, selling, subscribing for or underwriting (or exercising rights to acquire, dispose of or underwrite) any particular investment instrument. As such, you acknowledge that you are capable of interpreting the information provided in this document and using that information to take decisions as regards the merits of investing in particular investment instruments.

By accepting this document, you agree to be bound by the foregoing limitations.

The Royal Bank of Scotland plc. Registered in Scotland No 90312. Registered Office: 36 St Andrew Square, Edinburgh EH2 2YB. Authorised by the Prudential Regulation Authority (the “PRA”) and regulated by the Financial Conduct Authority ( the “FCA”) and the PRA. National Westminster Bank Plc.  Registered in England and Wales No 929027.  Registered Office: 135 Bishopsgate, London EC4M 3UR.  Authorised by the PRA and regulated by the FCA and PRA.  The Royal Bank of Scotland plc is authorised to act as agent for National Westminster Bank Plc.

Related articles

Outlooks for the rest of 2022
Five Federated Hermes funds awarded Austrian EcoLabel
Spectrum Q2 2022: Investing into the aluminium paradox
Federated Hermes appoints Orla Garvey as Senior PM in Global Fixed Income team
Climate Change High Yield Credit strategy, interim report 2022
Public declaration of voting recommendations 2022

Sales contacts

Clive Selman, Executive Director - Head of Distribution, UK & Ireland